Retour
32
7
Fourchette du Jour
13,19 €
13,70 €
Fourchette 52 Semaines
3,92 €
14,65 €
Volume
119 498
Moyenne 50J / 200J
12,15 €
/
8,61 €
Clôture Précédente
13,71 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 68,8 | 0,4 |
| P/B | 7,2 | 2,9 |
| ROE % | 11,4 | 3,9 |
| Net Margin % | 14,6 | 3,8 |
| Rev Growth 5Y % | 15,4 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
30,00 €
+122.2%
P/E Prévisionnel
70,31
BPA Prévisionnel
0,20 €
Croissance BPA (est.)
+0,0%
CA Est.
66,43M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
0,28 €
0,27 € – 0,29 €
|
105,72M | 1 |
| FY2027 |
0,28 €
0,20 € – 0,39 €
|
81,37M | 3 |
| FY2026 |
0,20 €
0,16 € – 0,26 €
|
66,43M | 3 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 15,42% annually over 5 years — strong growth
Earnings grew 163,39% over the past year
ROE of 11,35% — decent returns on equity
Debt/Equity of 0,09 — conservative balance sheet
Generating 16,40M in free cash flow
P/E of 68,83 — premium valuation
Croissance
Revenue Growth (5Y)
15,42%
Revenue (1Y)28,34%
Earnings (1Y)163,39%
FCF Growth (3Y)N/A
Qualité
Return on Equity
11,35%
ROIC4,08%
Net Margin14,62%
Op. Margin8,28%
Sécurité
Debt / Equity
0,09
Current Ratio3,83
Interest Coverage1,96
Valorisation
P/E Ratio
68,83
Forward P/EN/A
P/B Ratio7,23
EV/EBITDA107,49
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 28,34% | Revenue Growth (3Y) | 28,69% |
| Earnings Growth (1Y) | 163,39% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 15,42% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 52,64M | Net Income (TTM) | 7,69M |
| ROE | 11,35% | ROA | 6,81% |
| Gross Margin | 75,42% | Operating Margin | 8,28% |
| Net Margin | 14,62% | Free Cash Flow (TTM) | 16,40M |
| ROIC | 4,08% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,09 | Current Ratio | 3,83 |
| Interest Coverage | 1,96 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 68,83 | Forward P/E | N/A |
| P/B Ratio | 7,23 | P/S Ratio | 10,06 |
| PEG Ratio | 0,06 | Forward PEG | N/A |
| EV/EBITDA | 107,49 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 3,10% | ||
| Market Cap | 529,51M | Enterprise Value | 468,38M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 52,64M | 41,02M | 31,79M | 27,18M | 29,66M |
| Net Income | 7,69M | 2,92M | -4,20M | -13,35M | -6,46M |
| EPS (Diluted) | 0,36 | 0,09 | -0,13 | -0,43 | -0,21 |
| Gross Profit | 39,70M | 30,58M | 23,48M | 20,05M | 23,06M |
| Operating Income | 4,36M | 1,39M | -4,96M | -12,68M | -5,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 112,92M | 94,32M | 62,97M | 64,48M | 75,73M |
| Total Liabilities | 34,67M | 32,00M | 21,39M | 19,08M | 18,41M |
| Shareholders' Equity | 73,22M | 62,31M | 41,58M | 45,40M | 57,33M |
| Total Debt | 6,82M | 5,62M | 471 000,0 | 488 000,0 | 754 000,0 |
| Cash & Equivalents | 67,95M | 69,35M | 10,52M | 47,58M | 16,92M |
| Current Assets | 84,89M | 79,67M | 55,47M | 58,09M | 65,45M |
| Current Liabilities | 22,16M | 15,35M | 9,76M | 8,14M | 9,07M |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#787 of 1052
Custom
Full Throttle
#144 of 146
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Full Throttle
Mar 24, 2026